DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Royal Tulip Brasília Alvorada Hotel

2024 年 09 月 25 日 8:00 上午 - 2024 年 09 月 26 日 4:00 下午

Shtn - Trechno 01, Conj 1Bb - Bloco C, 40800-200 Brasília, Brazil

Latin America Annual Meeting

Take advantage of opportunities for networking and knowledge sharing with key stakeholders influencing the advancement and implementation of initiatives in Latin America.

Early Bird Rates Expire

DAYS

HOURS

MINUTES

SECONDS

Session 3, Track B: Challenges, Practices, and Governance in Pharmacovigilance and Technovigilance: Harmonization Efforts in Safety

Session Chair(s)

Rosana M. Mastellaro, PharmD, RPh

Rosana M. Mastellaro, PharmD, RPh

Director, Technical Regulatory Affairs and Innovation

Sindusfarma, Brazil

Josue  Bautista, PharmD

Josue Bautista, PharmD

GCP/PV Auditor

Novartis, Mexico

The session will cover various important topics related to pharmacovigilance (PV) and technovigilance. It will provide an overview of the current legislations in place for these fields, highlighting the roles of both ICH and non-ICH members. Participants will also be informed about the ongoing PV harmonization projects aimed at enhancing global safety monitoring systems. The session will include discussions on the influential role of UMC (Uppsala Monitoring Centre) and its active participation in the field. Furthermore, the session will shed light on the electronic transmission of safety information, ensuring efficient and timely exchange of data. The IMDRF framework and regional initiatives will be explored in the context of improving pharmacovigilance and technovigilance practices. Lastly, the session will emphasize the importance of reliance in pharmacovigilance and technovigilance, promoting trust and collaboration among stakeholders to ensure the safety of medicines and medical devices.

Learning Objective :
  • Know and understand the Pharmacovigilance and Technovigilance landscape in Latin America
  • Understand the level of implementation of ICH and IMDRF principles in Latin America, including the harmonization status across the region for expedited reporting, aggregate reporting, and risk management
  • To understand actions needed for reliance in the safety monitoring of medicines and medical devices

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。